All Stories

  1. TFOS Lifestyle: Impact of contact lenses on the ocular surface
  2. In vitro–in vivo correlation of drug release profiles from medicated contact lenses using an in vitro eye blink model
  3. Short-term tolerability of commercial eyelid cleansers: A randomised crossover study
  4. Antiviral Activity of Contemporary Contact Lens Care Solutions against Two Human Seasonal Coronavirus Strains
  5. The impact of contact lenses on meibomian gland morphology
  6. Clinical practice patterns in the management of dry eye disease: A TFOS international survey
  7. Bibliometric analysis of the meibomian gland literature
  8. CLEAR - Contact lens technologies of the future
  9. Developing evidence-based guidance for the treatment of dry eye disease with artificial tear supplements: A six-month multicentre, double-masked randomised controlled trial
  10. Bibliometric analysis of the literature relating to scleral contact lenses
  11. Activity of Deposited Lysozyme on Contemporary Soft Contact Lenses Exposed to Differing Lens Care Systems
  12. The Impact of Incubation Conditions on In Vitro Phosphatidylcholine Deposition on Contact Lens Materials
  13. Global optometrist top 200 research ranking
  14. In vitro analysis of the interaction of tear film inflammatory markers with contemporary contact lens materials
  15. The impact of patient behaviour and care system compliance on reusable soft contact lens complications
  16. Bibliometric analysis of the refractive error field
  17. Symptom Relief Following a Single Dose of Propylene Glycol-Hydroxypropyl Guar Nanoemulsion in Patients with Dry Eye Disease: A Phase IV, Multicenter Trial
  18. In vitro Evaluation of the Location of Cholesteryl Ester Deposits on Monthly Replacement Silicone Hydrogel Contact Lens Materials
  19. Thirty years of ‘quiet eye’ with etafilcon A contact lenses
  20. The ocular surface, coronaviruses and COVID ‐19
  21. Effect of Artificial Tear Formulations on the Metabolic Activity of Human Corneal Epithelial Cells after Exposure to Desiccation
  22. The Impact of Cosmetics on the Physical Dimension and Optical Performance of Contemporary Silicone Hydrogel Contact Lenses
  23. Kinetic Deposition of Polar and Non-polar Lipids on Silicone Hydrogel Contact Lenses
  24. The COVID-19 pandemic: Important considerations for contact lens practitioners
  25. Geographic distribution of corneal staining in symptomatic dry eye
  26. When was the last time you fitted a soft lens?
  27. Cytomorphological assessment of the lid margin in relation to symptoms, contact lens wear and lid wiper epitheliopathy
  28. The efficacy of povidone-iodine, hydrogen peroxide and a chemical multipurpose contact lens care system against Pseudomonas aeruginosa on various lens case surfaces
  29. Global trends in myopia management attitudes and strategies in clinical practice – 2019 Update
  30. Adhesion of Pseudomonas aeruginosa, Achromobacter xylosoxidans, Delftia acidovorans, Stenotrophomonas maltophilia to contact lenses under the influence of an artificial tear solution
  31. Localization of full-length recombinant human proteoglycan-4 in commercial contact lenses using confocal microscopy
  32. The use of preservatives in dry eye drops
  33. The short-term physiological impact of switching reusable silicone hydrogel wearers into a hydrogel daily disposable multifocal
  34. An Eyelid Warming Device for the Management of Meibomian Gland Dysfunction
  35. Hand hygiene is linked to microbial keratitis and corneal inflammatory events
  36. Novel in vitro method to determine pre-lens tear break-up time of hydrogel and silicone hydrogel contact lenses
  37. Efficacy of Contact Lens Care Solutions in Removing Cholesterol Deposits From Silicone Hydrogel Contact Lenses
  38. Efficacy of topical ophthalmic drugs in the treatment of dry eye disease: A systematic literature review
  39. The Case for Using Hydrogen Peroxide Contact Lens Care Solutions
  40. Uptake and Release of Polyvinyl Alcohol from Hydrogel Daily Disposable Contact Lenses
  41. IMI – Clinical Myopia Control Trials and Instrumentation Report
  42. IMI – Industry Guidelines and Ethical Considerations for Myopia Control Report
  43. IMI – Myopia Control Reports Overview and Introduction
  44. IMI – Report on Experimental Models of Emmetropization and Myopia
  45. Impact of a Hyaluronic Acid-Grafted Layer on the Surface Properties of Model Silicone Hydrogel Contact Lenses
  46. Clinical factors associated with contact lens dropout
  47. Determination of the release of PEG and HPMC from nelfilcon A daily disposable contact lenses using a novel in vitro eye model
  48. A novel scale for describing corneal staining
  49. Depth Profile Assessment of the Early Phase Deposition of Lysozyme on Soft Contact Lens Materials Using a Novel In Vitro Eye Model
  50. Comparison of meibomian gland dropout using two infrared imaging devices
  51. Short-Term Comfort Responses Associated With the Use of Eyelid Cleansing Products to Manage Demodex folliculorum
  52. The Impact of Scleral Contact Lens Vault on Visual Acuity and Comfort
  53. Analysis of polyvinyl alcohol release from commercially available daily disposable contact lenses using an in vitro eye model
  54. Spectacle prescriptions review to determine prevalence of ametropia and coverage of frequent replacement soft toric contact lenses
  55. Functional Two- and Three-Dimensional Architectures of Immobilized Metal Nanoparticles
  56. Surface versus bulk activity of lysozyme deposited on hydrogel contact lens materials in vitro
  57. Cytotoxic and inflammatory effects of contact lens solutions on human corneal epithelial cells in vitro
  58. Tear evaporation rates: What does the literature tell us?
  59. The Effect of Denatured Lysozyme on Human Corneal Epithelial Cells
  60. Differential Deposition of Fluorescently Tagged Cholesterol on Commercial Contact Lenses Using a Novel In Vitro Eye Model
  61. Tear osmolarity changes after use of hydroxypropyl-guar-based lubricating eye drops
  62. A Rapid Extraction Method to Quantify Drug Uptake in Contact Lenses
  63. Myopia prevalence in Canadian school children: a pilot study
  64. A single vectored thermal pulsation treatment for meibomian gland dysfunction increases mean comfortable contact lens wearing time by approximately 4 hours per day
  65. In Vitro Effect of Lysozyme on Albumin Deposition to Hydrogel Contact Lens Materials
  66. TFOS DEWS II Report Executive Summary
  67. In vitro release of two anti-muscarinic drugs from soft contact lenses
  68. A Review of Techniques to Measure Protein Sorption to Soft Contact Lenses
  69. Effect of Time on Scleral Lens Settling and Change in Corneal Clearance
  70. Lipid Deposition on Contact Lenses when Using Contemporary Care Solutions
  71. Degradation of proteoglycan 4/lubricin by cathepsin S: Potential mechanism for diminished ocular surface lubrication in Sjögren's syndrome
  72. Consensus report: how to diagnose dry eye
  73. TFOS DEWS II Epidemiology Report
  74. TFOS DEWS II Introduction
  75. TFOS DEWS II Management and Therapy Report
  76. TFOS DEWS II Tear Film Report
  77. Selectivity and localization of lysozyme uptake in contemporary hydrogel contact lens materials
  78. Self versus examiner administration of the Ocular Surface Disease Index©
  79. The relief of dry eye signs and symptoms using a combination of lubricants, lid hygiene and ocular nutraceuticals
  80. A Comparison of Dry Eye Diagnostic Tests Between Symptomatic and Asymptomatic Age-Matched Females
  81. A sixteen year survey of Canadian contact lens prescribing
  82. Release of Moxifloxacin from Contact Lenses Using an In Vitro Eye Model: Impact of Artificial Tear Fluid Composition and Mechanical Rubbing
  83. Pilot Study to Determine the Effect of Lens and Eye Rinsing on Solution-Induced Corneal Staining (SICS)
  84. Towards point-of-care detection of polymicrobial infections: Rapid colorimetric response using a portable spectrophotometer
  85. Effects of Antifungal Soaked Silicone Hydrogel Contact Lenses on Candida albicans in an Agar Eye Model
  86. Interactions between bacterial surface and nanoparticles govern the performance of “chemical nose” biosensors
  87. Impression Cytology of the Lid Wiper Area
  88. Prolonged Ocular Retention of Mucoadhesive Nanoparticle Eye Drop Formulation Enables Treatment of Eye Diseases Using Significantly Reduced Dosage
  89. Contact Lens Comfort
  90. Effect of Short Recovery Periods on Ocular Comfort During Daily Lens Wear
  91. Eyelid Margin and Meibomian Gland Characteristics and Symptoms in Lens Wearers
  92. Impact of Lens Care Solutions on Protein Deposition on Soft Contact Lenses
  93. Lid Wiper Epitheliopathy in Soft Contact Lens Wearers
  94. Microbial Contamination of Contact Lens Storage Cases During Daily Wear Use
  95. Subjective Comfort and Physiology with Modern Contact Lens Care Products
  96. Impact of Eye Cosmetics on the Eye, Adnexa, and Ocular Surface
  97. Corneal Swelling with Cosmetic etafilcon A Lenses versus No Lens Wear
  98. Development of an In Vitro Ocular Platform to Test Contact Lenses
  99. Assessment of biofilm formation of E. meningoseptica, D. acidovorans, and S. maltophilia in lens cases and their growth on recovery media
  100. Expert Views on Innovative Future Uses for Contact Lenses
  101. Global trends in myopia management attitudes and strategies in clinical practice
  102. Release of Fluconazole from Contact Lenses Using a Novel In Vitro Eye Model
  103. Revolutionary Future Uses of Contact Lenses
  104. The Use of Contact Lenses as Biosensors
  105. Variations in observable lid wiper epitheliopathy (LWE) staining patterns in wearers of silicone hydrogel lenses
  106. Colorimetric biosensing of pathogens using gold nanoparticles
  107. In Vitro Cholesterol Deposition on Daily Disposable Contact Lens Materials
  108. A Comparative Study Between an Oil-in-Water Emulsion and Nonlipid Eye Drops Used for Rewetting Contact Lenses
  109. Associations with Meibomian Gland Atrophy in Daily Contact Lens Wearers
  110. Controlling “chemical nose” biosensor characteristics by modulating gold nanoparticle shape and concentration
  111. Effect of Lid Debridement-Scaling in Sjögren Syndrome Dry Eye
  112. In vitro friction testing of contact lenses and human ocular tissues: Effect of proteoglycan 4 (PRG4)
  113. Biological and Clinical Implications of Lysozyme Deposition on Soft Contact Lenses
  114. Atomic force microscopy and Langmuir–Blodgett monolayer technique to assess contact lens deposits and human meibum extracts
  115. Competitive Effects from an Artificial Tear Solution to Protein Adsorption
  116. Impact of Cosmetics on the Physical Dimension and Optical Performance of Silicone Hydrogel Contact Lenses
  117. Impact of Cosmetics on the Surface Properties of Silicone Hydrogel Contact Lenses
  118. Analysis of Using I125Radiolabeling for Quantifying Protein on Contact Lenses
  119. Timolol maleate release from hyaluronic acid-containing model silicone hydrogel contact lens materials
  120. Release of Ciprofloxacin and Moxifloxacin From Daily Disposable Contact Lenses From an In Vitro Eye Model
  121. Efficacy of Antimicrobials against Biofilms of Achromobacter and Pseudomonas
  122. Clinical Performance of Three Silicone Hydrogel Daily Disposable Lenses
  123. Infrared Imaging of Meibomian Glands and Evaluation of the Lipid Layer in Sjogren's Syndrome Patients and Nondry Eye Controls
  124. Tear exchange and contact lenses: A review
  125. “Chemical nose” for the visual identification of emerging ocular pathogens using gold nanostars
  126. Kinetics of Competitive Adsorption between Lysozyme and Lactoferrin on Silicone Hydrogel Contact Lenses and the Effect on Lysozyme Activity
  127. In vitrodrug release of natamycin from β-cyclodextrin and 2-hydroxypropyl-β-cyclodextrin-functionalized contact lens materials
  128. Phenylboronic acid modified mucoadhesive nanoparticle drug carriers facilitate weekly treatment of experimentallyinduced dry eye syndrome
  129. Extended Latanoprost Release from Commercial Contact Lenses: In Vitro Studies Using Corneal Models
  130. Comparative Study of Lens Solutions’ Ability to Remove Tear Constituents
  131. Extraction versus In Situ Techniques for Measuring Surface-Adsorbed Lysozyme
  132. In Vitro and In Vivo Evaluation of Novel Ciprofloxacin-Releasing Silicone Hydrogel Contact Lenses
  133. Repeatability of Grading Meibomian Gland Dropout Using Two Infrared Systems
  134. Identification of coagulase-negative staphylococci in daily disposable contact lens wearers
  135. Contact lenses for antifungal ocular drug delivery: a review
  136. Branching and size of CTAB-coated gold nanostars control the colorimetric detection of bacteria
  137. Silicone Allergies and the Eye
  138. Quantification of Conjunctival TNF-α in Aqueous-Deficient Dry Eye
  139. A multi-country assessment of compliance with daily disposable contact lens wear
  140. Human Corneal Epithelial Cell Shedding and Fluorescein Staining in Response to Silicone Hydrogel Lenses and Contact Lens Disinfecting Solutions
  141. The TFOS International Workshop on Contact Lens Discomfort: Executive Summary
  142. The TFOS International Workshop on Contact Lens Discomfort: Introduction
  143. The TFOS International Workshop on Contact Lens Discomfort: Report of the Contact Lens Interactions With the Ocular Surface and Adnexa Subcommittee
  144. The TFOS International Workshop on Contact Lens Discomfort: Report of the Contact Lens Materials, Design, and Care Subcommittee
  145. Factors that Influence In Vitro Cholesterol Deposition on Contact Lenses
  146. In vitrouptake and release of natamycin Dex-b-PLA nanoparticles from model contact lens materials
  147. Comfort Response of Three Silicone Hydrogel Daily Disposable Contact Lenses
  148. Re: Putting vital stains in context
  149. Exploring Compliance
  150. Imaging meibomian glands on a patient with chalazia in the upper and lower lids: A case report
  151. Contemporary dry eye tests
  152. Impact of Silicone Hydrogel Lenses and Solutions on Corneal Epithelial Permeability
  153. Inhibition of Defocus-Induced Myopia in Chickens
  154. Impact of tear film components on the conformational state of lysozyme deposited on contact lenses
  155. Compliance with Lens Replacement and the Interval between Eye Examinations
  156. In Vitro Uptake and Release of Natamycin From Conventional and Silicone Hydrogel Contact Lens Materials
  157. Physical Entrapment of Hyaluronic Acid During Synthesis Results in Extended Release From Model Hydrogel and Silicone Hydrogel Contact Lens Materials
  158. Impact of Time Between Collection and Collection Method on Human Tear Fluid Osmolarity
  159. Optimization of a Fluorescence-based Lysozyme Activity Assay for Contact Lens Studies
  160. 2. Contact lens care and ocular surface homeostasis
  161. 3. Ocular surface health with contact lens wear
  162. Historical overview of imaging the meibomian glands
  163. The Impact of Contemporary Contact Lenses on Contact Lens Discontinuation
  164. Uptake and Release Phenomena in Contact Lens Care by Silicone Hydrogel Lenses
  165. Wettability and Silicone Hydrogel Lenses
  166. Development of Mucoadhesive Drug Delivery System Using Phenylboronic Acid Functionalized Poly(D,L-lactide)-b-Dextran Nanoparticles
  167. The Impact of Intermittent Air Exposure on Lipid Deposition
  168. Measuring the Modulus of Silicone Hydrogel Contact Lenses
  169. Protein Deposition and Clinical Symptoms in Daily Wear of Etafilcon Lenses
  170. Measuring the kinetics and activity of adsorbed proteins:In vitrolysozyme deposited onto hydrogel contact lenses over short time periods
  171. Delivery of Ketotifen Fumarate by Commercial Contact Lens Materials
  172. Molecular Structure of Interfacial Human Meibum Films
  173. The Impact of Tear Film Components on In Vitro Lipid Uptake
  174. Using anIn VitroModel of Lipid Deposition to Assess the Efficiency of Hydrogen Peroxide Solutions to Remove Lipid from Various Contact Lens Materials
  175. Photocrosslinkable hyaluronic acid as an internal wetting agent in model conventional and silicone hydrogel contact lenses
  176. The effects of hyaluronic acid incorporated as a wetting agent on lysozyme denaturation in model contact lens materials
  177. Infrared Imaging of Meibomian Gland Structure Using a Novel Keratograph
  178. Nanomaterials for Ocular Drug Delivery
  179. Impact of Tear Film Components on Lysozyme Deposition to Contact Lenses
  180. Protein deposition on contact lenses: The past, the present, and the future
  181. Correction
  182. Use of a Photographic Manipulation Tool to Assess Corneal Vascular Response
  183. Acetic and Acrylic Acid Molecular Imprinted Model Silicone Hydrogel Materials for Ciprofloxacin-HCl Delivery
  184. The Competing Effects of Hyaluronic and Methacrylic Acid in Model Contact Lenses
  185. Utilization of in vitro methods to determine the biocompatibility of intraocular lens materials
  186. Ability of patients to recall habitual contact lens products and enhancement of recall using photographic aids
  187. Quantification of Non-Polar Lipid Deposits on Senofilcon A Contact Lenses
  188. The University of Waterloo's Centre for Contact Lens Research
  189. The relationship between compliance with lens replacement and contact lens-related problems in silicone hydrogel wearers
  190. Influence of Protein Deposition on Bacterial Adhesion to Contact Lenses
  191. Hyaluronic acid as an internal wetting agent in model DMAA/TRIS contact lenses
  192. Outcomes of wavefront-guided laser in situ keratomileusis for hyperopia
  193. Impact of Multipurpose Solutions Released from Contact Lenses on Corneal Cells
  194. In Vitro Analysis of the Physical Properties of Contact Lens Blister Pack Solutions
  195. Patient Use of Smartphones to Communicate Subjective Data in Clinical Trials
  196. Effects of Silicone Hydrogel Contact Lens Wear on Ocular Surface Sensitivity to Tactile, Pneumatic Mechanical, and Chemical Stimulation
  197. Impact of a Rub and Rinse on Solution-Induced Corneal Staining
  198. Repeatability of Pachymetry and Thinnest Point Localization Using a Fourier-Domain Optical Coherence Tomographer
  199. Clinical performance of different care systems with silicone hydrogel contact lenses
  200. Innovation in contact lenses: basic research and clinical science
  201. Impact of fluorescent probes on albumin sorption profiles to ophthalmic biomaterials
  202. Influence of the Blink Interval on Tear Meniscus Height in Soft Contact Lens and Nonlens Wearers
  203. Tear lipocalin and lysozyme concentrations in postmenopausal women
  204. Comfort and Vision with Silicone Hydrogel Lenses: Effect of Compliance
  205. The Impact of Contact Angle on the Biocompatibility of Biomaterials
  206. Contact Lens Cases: The Missing Link in Contact Lens Safety?
  207. Compliance with Contact Lens Replacement in Canada and the United States
  208. Confocal microscopy and optical coherence tomography imaging of hereditary granular dystrophy
  209. Ex Vivo Protein Deposition on Bi-Weekly Silicone Hydrogel Contact Lenses
  210. In Vitro Contact Angle Analysis and Physical Properties of Blister Pack Solutions of Daily Disposable Contact Lenses
  211. Kinetics of Lysozyme Activity Recovered from Conventional and Silicone Hydrogel Contact Lens Materials
  212. Determination of albumin sorption to intraocular lenses by radiolabeling and confocal laser scanning microscopy
  213. Ex Vivo Protein Deposition on Bi-Weekly Silicone Hydrogel Contact Lenses
  214. Impact of Protein and Lipid on Neutralization Times of Hydrogen Peroxide Care Regimens
  215. Tear Meniscus Height Determination Using the OCT2 and the RTVue-100
  216. Uptake and Release of Dexamethasone Phosphate From Silicone Hydrogel and Group I, II, and IV Hydrogel Contact Lenses
  217. Patient and Practitioner Compliance With Silicone Hydrogel and Daily Disposable Lens Replacement in the United States
  218. Wavefront-guided LASIK for Myopia: Effect on Visual Acuity, Contrast Sensitivity, and Higher Order Aberrations
  219. Contact lens induced papillary conjunctivitis with silicone hydrogel lenses
  220. Efficacy of an Extraction Solvent Used to Quantify Albumin Deposition on Hydrogel Contact Lens Materials
  221. Protein Deposition on a Lathe-Cut Silicone Hydrogel Contact Lens Material
  222. Kinetics of in Vitro Lactoferrin Deposition on Silicone Hydrogel and FDA Group II and Group IV Hydrogel Contact Lens Materials
  223. Localization of Lysozyme Sorption to Conventional and Silicone Hydrogel Contact Lenses Using Confocal Microscopy
  224. Imaging Protein Deposits on Contact Lens Materials
  225. Thickness Mapping of the Cornea and Epithelium Using Optical Coherence Tomography
  226. Conjunctival and Corneal Hyperesthesia in Subjects with Dryness Symptoms
  227. Quartz crystal microbalance study of protein adsorption kinetics on poly(2-hydroxyethyl methacrylate)
  228. Albumin adsorption to contact lens materials: A review
  229. Dry Eye Symptoms Assessed by Four Questionnaires
  230. Epithelial Thickness Changes from the Induction of Myopia with CRTH RGP Contact Lenses
  231. Subjective and Objective Variation of the Tear Film Pre- and Post-Sleep
  232. Tear Lipocalin and Lysozyme in Sj??gren and Non-Sjogren Dry Eye
  233. Size-dependent denaturing kinetics of bovine serum albumin adsorbed onto gold nanospheres
  234. Clinical signs and symptoms in post-menopausal females with symptoms of dry eye
  235. Comfort and Adaptation to Silicone Hydrogel Lenses for Daily Wear
  236. Conjunctival and Corneal Pneumatic Sensitivity Is Associated with Signs and Symptoms of Ocular Dryness
  237. Hyaluronic acid containing hydrogels for the reduction of protein adsorption
  238. Atypical manifestation of upper lid margin staining in silicone hydrogel lens wearers with symptoms of dry eye
  239. Physical Properties of Soft Contact Lens Solutions
  240. A Solid-Phase Assay for the Quantitation of Total Protein Eluted from Balafilcon, Lotrafilcon, and Etafilcon Contact Lenses
  241. Conformational and Quantitative Characterization of Lysozyme Extracted from Galyfilcon and Senofilcon Silicone Hydrogel Contact Lenses
  242. Immobilized hyaluronic acid containing model silicone hydrogels reduce protein adsorption
  243. Microbial Keratitis and the Role of Rub and Rinsing
  244. The Impact of Lipid on Contact Angle Wettability
  245. Apparent time-dependent differences in inferior tear meniscus height in human subjects with mild dry eye symptoms
  246. Confocal Microscopy and Albumin Penetration into Contact Lenses
  247. Variability of the Analysis of the Tear Meniscus Height by Optical Coherence Tomography
  248. Extraction Efficiency of an Extraction Buffer Used to Quantify Lysozyme Deposition on Conventional and Silicone Hydrogel Contact Lens Materials
  249. Growth Factors in the Tear Film: Role in Tissue Maintenance, Wound Healing, and Ocular Pathology
  250. Tear Osmolality and Ferning Patterns in Postmenopausal Women
  251. A Seven Year Survey of the Contact Lens Prescribing Habits of Canadian Optometrists
  252. Assessment of Variation in Bulbar Conjunctival Redness, Temperature, and Blood Flow
  253. Quantity and Conformation of Lysozyme Deposited on Conventional and Silicone Hydrogel Contact Lens Materials Using an In Vitro Model
  254. Contact Lenses in Suboptimal Environments
  255. Corneal Refractive Therapy with Different Lens Materials, Part 1: Corneal, Stromal, and Epithelial Thickness Changes
  256. Lipid Deposition on Hydrogel Contact Lenses: How History Can Help Us Today
  257. In Vitro Assessment of Medical Device Toxicity: Interactions of Benzalkonium Chloride With Silicone-Containing and p-HEMA???Containing Hydrogel Contact Lens Materials
  258. Objective and Subjective Responses in Patients Refitted to Daily-Wear Silicone Hydrogel Contact Lenses
  259. Anomalous thermal denaturing of proteins adsorbed to nanoparticles
  260. Rewetting Drops Containing Surface Active Agents Improve the Clinical Performance of Silicone Hydrogel Contact Lenses
  261. Validity of Pachymetric Measurements by Manipulating the Acoustic Factor of Orbscan II
  262. Kinetics ofIn VitroLysozyme Deposition on Silicone Hydrogel, PMMA, and FDA Groups I, II, and IV Contact Lens Materials
  263. Soft Lens Extended Wear and Complications
  264. Subconjunctival cyst-like formations following impression cytology
  265. Stabilization of Lysozyme Mass Extracted From Lotrafilcon Silicone Hydrogel Contact Lenses
  266. Corneal and Epithelial Thickness Changes After 4 Weeks of Overnight Corneal Refractive Therapy Lens Wear, Measured With Optical Coherence Tomography
  267. Drying methods for XPS analysis of PureVision™, Focus® Night&Day™ and conventional hydrogel contact lenses
  268. Corrigendum to “Tear turnover rate is reduced in patients with symptomatic dry eye” [Contact Lens Anterior Eye 27 (2004) 15–20]
  269. Tear turnover rate is reduced in patients with symptomatic dry eye
  270. Quantitative and conformational characterization of lysozyme deposited on balafilcon and etafilcon contact lens materials
  271. Survey of Bandage Lens Use in North America, October???December 2002
  272. Topographical Thickness of the Epithelium and Total Cornea after Overnight Wear of Reverse-Geometry Rigid Contact Lenses for Myopia Reduction
  273. Precorneal and Pre- and Postlens Tear Film Thickness Measured Indirectly with Optical Coherence Tomography
  274. In vitro uptake and release studies of ocular pharmaceutical agents by silicon-containing and p-HEMA hydrogel contact lens materials
  275. Ciprofloxacin Interaction with Silicon-Based and Conventional Hydrogel Contact Lenses
  276. Asymptomatic Corneal Staining Associated with the Use of Balafilcon Silicone-Hydrogel Contact Lenses Disinfected with a Polyaminopropyl Biguanide-Preserved Care Regimen
  277. In vitro evaluation of the dehydration characteristics of silicone hydrogel and conventional hydrogel contact lens materials
  278. Relation between optical coherence tomography and optical pachymetry measurements of corneal swelling induced by hypoxia
  279. The application of counter immunoelectrophoresis (CIE) in ocular protein studies
  280. The measurement of corneal epithelial thickness in response to hypoxia using optical coherence tomography11Proprietary interests: The authors have no proprietary interest in any materials or methods described within this article.
  281. Non-inflammatory corneal complications of contact lens wear
  282. The ex vivo wettability of soft contact lenses
  283. An in Vivo Comparison of the Kinetics of Protein and Lipid Deposition on Group II and Group IV Frequent-Replacement Contact Lenses
  284. Epithelial Inclusions in Association with Mucin Ball Development in High-Oxygen Permeability Hydrogel Lenses
  285. Use of reverse geometry rigid gas permeable contact lenses in the management of the postradial keratotomy patient: review and case report
  286. Clinical comparison of three polyhexanide-preserved multi-purpose contact lens solutions
  287. Spoliation and Clinical Performance of Monthly vs. Three Monthly Group II Disposable Contact Lenses
  288. Disposable contact lenses: a review
  289. Effect of hydrogen peroxide neutralisation onthe fitting characteristics of group IV disposable contact lenses
  290. Pseudomonas corneal ulcers associated with daily wear of disposable hydrogel contact lenses
  291. Corneal ulcers associated with daily wear of disposable hydrogel contact lenses
  292. Possible allergic reactions to cyclopentolate hydrochloride: case reports with literature review of uses and adverse reactions
  293. Bitoric hard and soft lenses in marked ocularastigmatism